Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D, Mari D, Graziano F, Isidori P, Cetto G, Pasini F, Santo A, Cellerino R. Tummarello D, et al. Among authors: cetto g. Cancer. 1997 Dec 15;80(12):2222-9. Cancer. 1997. PMID: 9404698 Clinical Trial.
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis.
Santo A, Pedersini R, Pasini F, Terzi A, Pari F, Cartei G, Sibau A, Molino A, Maiorino A, Panza N, Oletti MV, Maluta S, Calabrò F, Cetto GL. Santo A, et al. Among authors: cetto gl. Lung Cancer. 2001 Dec;34 Suppl 4:S15-20. doi: 10.1016/s0169-5002(01)00400-7. Lung Cancer. 2001. PMID: 11742697 Clinical Trial.
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.
Piga A, Nortilli R, Cetto GL, Cardarelli N, Fedeli SL, Fiorentini G, D'Aprile M, Giorgi F, Parziale AP, Contu A, Montironi R, Gesuita R, Carle F, Cellerino R. Piga A, et al. Among authors: cetto gl. Br J Cancer. 2004 May 17;90(10):1898-904. doi: 10.1038/sj.bjc.6601785. Br J Cancer. 2004. PMID: 15138469 Free PMC article. Clinical Trial.
Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.
Tummarello D, Graziano F, Isidori P, Santo A, Cetto G, Fedeli A, Rossi G, Cellerino R. Tummarello D, et al. Among authors: cetto g. Cancer. 1996 Jun 1;77(11):2251-7. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2251::AID-CNCR11>3.0.CO;2-W. Cancer. 1996. PMID: 8635092 Clinical Trial.
Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D, Graziano F, Mari D, Cetto G, Pasini F, Antonio S, Isidori P, Gasparini S. Tummarello D, et al. Among authors: cetto g. Anticancer Res. 1994 Sep-Oct;14(5B):2221-7. Anticancer Res. 1994. PMID: 7840527 Clinical Trial.
110 results